| Literature DB >> 35965347 |
Il-Han Yoo1, Jeong-Min Kim2, Su-Hyun Han3, Jaiyoung Ryu4, Keun-Hwa Jung5, Kwang-Yeol Park3.
Abstract
BACKGROUND: Higher pulsatility of the middle cerebral artery (MCA) is known to be associated with stroke progression. We investigated whether pulsatility index (PI) of the basilar artery (BA) can predict neurological deterioration (ND) after acute cerebral infarction.Entities:
Keywords: Basilar artery; Neurological deterioration; Stroke; Transcranial Doppler sonography
Year: 2022 PMID: 35965347 PMCID: PMC9377089 DOI: 10.1186/s40885-022-00210-9
Source DB: PubMed Journal: Clin Hypertens ISSN: 2056-5909
Clinical characteristics of the study population according to BA PI
| Characteristics | Group 1 | Group 2 | Group 3 | Group 4 | |
|---|---|---|---|---|---|
| Age (yr) | 59.7 ± 14.0 | 66.5 ± 12.0 | 72.0 ± 10.4 | 76.3 ± 8.7 | < 0.001*** |
| Female sex | 73 (41.0) | 90 (46.9) | 119 (54.3) | 65 (54.6) | 0.031* |
| Neurological deterioration | 19 (10.7) | 20 (10.4) | 28 (12.8) | 25 (21.0) | 0.033* |
| Hypertension | 96 (53.9) | 121 (63.0) | 147 (67.1) | 96 (80.7) | < 0.001*** |
| Diabetes mellitus | 39 (21.9) | 64 (33.3) | 87 (39.7) | 49 (41.2) | 0.001** |
| Current smoking | 53 (29.8) | 50 (26.0) | 62 (28.3) | 28 (23.5) | 0.644 |
| Atrial fibrillation | 29 (16.3) | 40 (20.8) | 42 (19.2) | 31 (26.1) | 0.220 |
| Previous stroke | 40 (22.5) | 37 (19.3) | 44 (20.1) | 31 (26.1) | 0.497 |
| SBP (mmHg) | 144.8 ± 25.8 | 144.5 ± 26.6 | 150.4 ± 28.1 | 149.1 ± 26.9 | 0.074 |
| Hematocrit | 41.0 ± 6.3 | 40.8 ± 5.6 | 39.6 ± 5.5 | 40.0 ± 5.5 | 0.068 |
| Leukocytes (109/L) | 7.80 ± 2.83 | 8.62 ± 6.46 | 8.41 ± 3.24 | 8.04 ± 3.67 | 0.157 |
| Fasting blood glucose (mmol/L) | 3.40 ± 1.51 | 3.70 ± 1.45 | 3.71 ± 1.57 | 3.87 ± 1.67 | 0.065 |
| HbA1c (%) | 5.99 ± 1.35 | 6.07 ± 1.32 | 6.37 ± 1.43 | 6.31 ± 1.34 | 0.027* |
| Total cholesterol (mmol/L) | 4.81 ± 1.26 | 4.67 ± 1.31 | 4.74 ± 1.25 | 4.67 ± 1.30 | 0.680 |
| LDL cholesterol (mmol/L) | 2.81 ± 0.89 | 2.77 ± 0.95 | 2.79 ± 0.89 | 2.75 ± 0.90 | 0.943 |
| hsCRP (mmol/L) | 0.17 ± 0.57 | 0.19 ± 0.57 | 0.22 ± 0.64 | 0.37 ± 1.06 | 0.278 |
| Homocysteine (μmol/L) | 14.94 ± 7.53 | 14.61 ± 6.28 | 15.19 ± 6.20 | 16.77 ± 6.89 | 0.051 |
| Right MCA PI ( | 0.75 ± 0.13 ( | 0.87 ± 0.13 ( | 1.02 ± 0.16 ( | 1.23 ± 0.20 ( | < 0.001*** |
| Left MCA PI ( | 1.26 ± 6.32 ( | 0.86 ± 0.11 ( | 1.03 ± 0.16 ( | 1.21 ± 0.21 ( | < 0.001*** |
| Cerebral microbleeds | 70 (39.3) | 86 (44.8) | 101 (46.1) | 55 (46.2) | 0.520 |
| Old lacunes | 104 (58.4) | 121 (63.0) | 162 (74.0) | 90 (75.6) | 0.001** |
| CAS | 2 (0–5) | 3 (0–6) | 4 (1–7) | 4 (2–6) | 0.181 |
| WMH lesion | 97 (54.5) | 148 (77.1) | 190 (86.8) | 105 (88.2) | < 0.001*** |
| NIHSS score at admission | 2 (0–5) | 2 (0–5) | 2 (1–6) | 3 (1–7) | 0.079 |
Values are presented as means ± standard deviation, number (%), or median (interquartile range). Differences between groups were analyzed using the analysis of chi-square test and the one-way analysis of variance test. Kruskal-Wallis tests were used to compare the CAS between groups
BA Basilar artery, PI Pulsatility index, SBP Systolic blood pressure, HbA1c Hemoglobin A1c, LDL Low-density lipoprotein, hsCRP High sensitivity C-reactive protein, MCA Right middle cerebral artery, CAS Cerebral atherosclerosis score, WMH White matter hyperintensity, NIHSS National Institutes of Health Stroke Scale
a) BA PI, 0.42–0.80; b) BA PI, 0.80–0.94; c) BA PI, 0.94–1.10; d) BA PI, 1.10–2.50
*P < 0.05, **P < 0.01, ***P < 0.001
Comparison among patients with and without neurological deterioration a)
| Variable | Neurological deterioration (−) ( | Neurological deterioration (+) ( | |
|---|---|---|---|
| Age (yr) | 67.7 ± 13.2 | 71.2 ± 11.2 | 0.016* |
| Female sex | 293 (47.6) | 54 (58.7) | 0.060** |
| Hypertension | 396 (64.3) | 64 (69.6) | 0.383 |
| Diabetes mellitus | 206 (33.4) | 33 (35.9) | 0.733 |
| Current smoking | 177 (28.7) | 16 (17.4) | 0.031* |
| Atrial fibrillation | 113 (18.3) | 29 (31.5) | 0.005* |
| Previous stroke | 129 (20.9) | 23 (25.0) | 0.454 |
| SBP (mmHg) | 146.3 ± 27.1 | 153.2 ± 25.7 | 0.023* |
| Hematocrit | 40.4 ± 5.9 | 40.4 ± 5.0 | 0.954 |
| Leukocytes (109/L) | 8.21 ± 4.43 | 8.51 ± 3.75 | 0.485 |
| Fasting blood glucose (mmol/L) | 3.65 ± 1.59 | 3.70 ± 1.19 | 0.704 |
| HbA1c (%) | 6.20 ± 1.42 | 6.07 ± 1.04 | 0.278 |
| Total cholesterol (mmol/L) | 4.74 ± 1.30 | 4.67 ± 1.07 | 0.565 |
| LDL cholesterol (mmol/L) | 2.78 ± 0.92 | 2.77 ± 0.84 | 0.898 |
| hsCRP (mmol/L) | 0.22 ± 0.67 | 0.25 ± 0.85 | 0.725 |
| Homocysteine (μmol/L) | 15.40 ± 6.92 | 14.16 ± 5.09 | 0.043* |
| Basilar artery PI | 0.95 ± 0.22 | 1.02 ± 0.26 | 0.014* |
| Right MCA PI ( | 0.92 ± 0.21 ( | 0.97 ± 0.27 ( | 0.285 |
| Left MCA PI ( | 1.09 ± 3.70 ( | 0.96 ± 0.24 ( | 0.170 |
| Cerebral microbleeds | 267 (43.3) | 45 (48.9) | 0.373 |
| Old lacunes | 416 (67.5) | 61 (66.3) | 0.908 |
| CAS | 3 (0–6) | 5 (2–8) | 0.002*** |
| WMH lesion | 461 (74.8) | 79 (85.9) | 0.029* |
| NIHSS score at admission | 2 (0–5) | 6 (3–9) | < 0.001*** |
Values are presented as means ± standard deviation, number (%), or median (interquartile range). Differences between groups were analyzed using the analysis of chi-square test and one-way analysis of variance test. Mann-Whitney U-tests were used for comparing NIHSS and CAS between groups
SBP Systolic blood pressure, HbA1c Hemoglobin A1c, LDL Low-density lipoprotein, hsCRP High sensitivity C-reactive protein, PI Pulsatility index, MCA Right middle cerebral artery, CAS Cerebral atherosclerosis score, WMH White matter hyperintensity, NIHSS National Institutes of Health Stroke Scale
a) Univariably significant with a P-value of ≤0.10 and considered in a multivariable model
*P < 0.05, **P < 0.1, ***P < 0.01
Logistic regression analysis for the determinants of early neurological deterioration
| Variable | Bivariable analyses | Multivariable analyses | ||
|---|---|---|---|---|
| OR (95% CI) | Adjusted OR (95% CI)a) | |||
| BA PI | 3.59 (1.45–8.81) | 0.005 | 3.28 (1.07–10.17) | 0.038 |
| BA PI, quartileb) | ||||
| Q1 (0.42–0.80) | 1 | 1 | ||
| Q2 (0.80–0.94) | 0.97 (0.50–1.89) | 0.935 | 0.93 (0.45–1.90) | 0.841 |
| Q3 (0.94–1.10) | 1.23 (0.66–2.28) | 0.518 | 1.05 (0.52–2.15) | 0.890 |
| Q4 (1.10–2.50) | 2.22 (1.16–4.26) | 0.016** | 2.39 (1.10–5.25) | 0.028 |
BA PI measured by transcranial Doppler ultrasonography
OR Odds ratio, CI Confidence interval, BA PI Basilar artery pulsatility index
a) Adjusted by age, sex, history of atrial fibrillation, current smoking status, National Institutes of Health Stroke Scale at admission, systolic blood pressure, serum homocysteine level, cerebral atherosclerosis score, and white matter hyperintensity lesion. b) Group was divided into quartiles based on BA PI
*P < 0.01, P < 0.05